Thumzup Welcomes The Gym Venice to Its Exclusive Cash Rewards Platform: A Heartfelt and Insightful Partnership

Thumzup® Welcomes The Gym Venice to its Proprietary Cash Rewards Platform Exciting News for Fitness Enthusiasts in Los Angeles Los Angeles, CA, Oct. 27, 2023 (GLOBE NEWSWIRE) — Thumzup Media Corporation (“Thumzup” or the “Company”) (OTCQB: TZUP) Thumzup Media Corporation is thrilled to announce the addition of The Gym Venice to its innovative cash rewards…

Read More

“Energy Transfer: Why Now is the Time to Buy – A Strong Investment Opportunity”

Welcome to our Blog! Energy Transfer LP: A Strong Investment Opportunity The Benefits of Trump’s Energy Policies Energy Transfer LP (ET) is well-positioned to benefit from President Trump’s energy policies, which have been focused on promoting domestic energy production and infrastructure development. With a strong presence in natural gas and crude oil transportation, ET is…

Read More

“5 Compelling Reasons to Invest in Chipotle Mexican Grill Stock – A Must-Have for Your Portfolio!”

The Rise of Chipotle Mexican Grill An All-Time High for Chipotle The stock of Chipotle Mexican Grill (CMG -0.02%) closed at its all-time high of $68.55 on June 18, 2024. It was a moment that captured the attention of investors, who were intrigued by the fast-casual restaurant chain’s impressive growth in comparable-store sales (comps), strong…

Read More

FingerMotion’s Subsidiary, Shanghai Jiuge Information Technology, Partners with Suning.com to Expand Top-Up Service to Major E-Commerce Portal

FingerMotion’s Subsidiary Shanghai JiuGe Information Technology & Suning.com Expansion October 2020 Warrants Extended New York, NY, Oct. 19, 2022 (GLOBE NEWSWIRE) — FingerMotion, Inc. (“FingerMotion” or the “Company”)(Nasdaq: FNGR), a mobile data and services company, is pleased to announce a cooperation agreement between Suning.com and FingerMotion’s subsidiary, Shanghai JiuGe Information Technology Co., Ltd (“JiuGe”). The…

Read More

Get Ready to Geek Out: Reviva Pharmaceuticals Shares Exciting Clinical Data on Brilaroxazine at ASPET 2023 Annual Meeting!

Reviva Pharmaceuticals Announces Presentation at Scientific Conference Exciting news from Reviva Pharmaceuticals as they recently announced a presentation at a scientific conference highlighting the latest data on brilaroxazine. The data reinforces brilaroxazine’s differentiated clinical pharmacology and safety profile, setting it apart from other drugs on the market. Unique Co-administration Potential One of the standout findings…

Read More